Edoxaban was at least as effective as warfarin in preventing thromboembolism after bioprosthetic valve replacement in the ...

With restored circulation, the TAH allowed Harbison to regain enough strength within 10 days to also undergo a heart ...

Abbott has taken a step forward in the development of a new addition to its structural heart portfolio, completing the first ...

Edoxaban, a medication taken orally to prevent blood clots from forming, was found to be as effective and safe for stroke and ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...

Objective: To assess the benefit for patients older than 65 years of aortic valve replacement with stentless biological heart valves in comparison with mechanical valves. Design: Multiple regression ...

Designed for patients needing a replacement valve, the company’s TAVI trial has found low rates of mortality after a year of ...

This historical growth is driven by an aging population leading to a rise in valvular heart disease, an increase in risk factors such as obesity and hypertension, advancements in diagnostic and ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...

University Hospital Galway is the first hospital in the country to use a new biological aortic heart valve, putting it at the ...

As the global population continues to age, the demand for heart valve replacement and repair procedures rises, driven by the ...

University Hospital Galway has become the first hospital in the country to use a new biological aortic heart valve on a patient.